Atlas Trials

A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps

Clinical trial NCT06801353 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06801353
Sponsor
Beijing Tongren Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)Biological TherapyBiomarkers
Start date
2025-02-01
Primary completion
2025-12-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.